drugset / Trial / NCT00178269

Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix

NCT00178269 ↗

Phase 2 Completed University of Rochester
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to find out how effectively cervix cancer is controlled when radiation is combined with low-dose chemotherapy (Taxotere) . The use of low-dose Taxotere, once per week, with radiation is a new treatment for cervical cancer. This study will also see how well this treatment regimen can be tolerated.

Timeline

Start
2005-01
Primary completion
2006-06
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule — —